Triochem Products Limited Re-submits Q3FY26 Unaudited Standalone Financial Results After Correcting Typographical Error

2 min read     Updated on 23 Feb 2026, 01:15 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Triochem Products Limited re-submitted its Q3FY26 unaudited standalone financial results after correcting a typographical error in the Limited Review Report following BSE's regulatory observation. The company reported a net loss of Rs. 13.18 lakhs for Q3FY26 compared to a profit of Rs. 8.83 lakhs in Q3FY25, with total income declining to Rs. 22.06 lakhs from Rs. 45.85 lakhs year-over-year. The Board approved asset sales worth over Rs. 1,100 lakhs in fair market value to support future business ventures.

powered bylight_fuzz_icon
33378348

*this image is generated using AI for illustrative purposes only.

Triochem Products Limited has re-submitted its unaudited standalone financial results for the quarter and nine months ended 31st December 2025 to BSE Limited, following regulatory observations regarding a typographical error in the Limited Review Report. The pharmaceutical company corrected the period mentioned in the report from December 31, 2024 to December 31, 2025.

Financial Performance Overview

The company's financial performance for Q3FY26 showed challenging results across key metrics:

Metric Q3FY26 Q3FY25 Change
Total Income Rs. 22.06 lakhs Rs. 45.85 lakhs -51.9%
Net Loss/Profit Rs. (13.18) lakhs Rs. 8.83 lakhs Loss
Basic EPS Rs. (5.38) Rs. 3.60 Negative

For the nine-month period ended December 31, 2025, the company reported a net loss of Rs. 35.50 lakhs compared to a net profit of Rs. 5.17 lakhs in the corresponding period of the previous year.

Regulatory Compliance and Re-submission

BSE Limited had issued a non-compliance notice dated 20th February 2026 under Regulation 33 of SEBI (LODR) Regulations, 2015, highlighting the typographical error in the Limited Review Report. The company acknowledged the error and confirmed that there were no changes in the actual financial results, only the correction of the wrong period mentioned in the auditor's report.

The Board of Directors approved the financial results at its meeting held on Friday, 13th February 2026, with Mr. Ramu S. Deora, Director, serving as the Chairperson of the meeting.

Operational and Strategic Developments

The company operates in a single segment of chemicals and pharmaceuticals. During the period, Triochem Products received shareholder approval on 13th December 2025 for the sale of immovable properties, plant & machinery, and investment property situated in Maharashtra.

Asset Sale Details Value
Written Down Value Rs. 56.92 lakhs
Fair Market Value (P&M) Rs. 672.05 lakhs
Fair Market Value (Investment Property) Rs. 509.00 lakhs

The assets have been classified as 'Assets Held for Sale' in accordance with Ind AS 105, with the transaction expected to be completed on or before 31st March 2026. The proceeds are intended for new business ventures and strategic initiatives.

Expense Analysis

The company's expense structure for Q3FY26 included employee benefit expenses of Rs. 14.44 lakhs, other expenditure of Rs. 23.62 lakhs, and depreciation expenses of Rs. 1.36 lakhs, totaling Rs. 39.42 lakhs against total income of Rs. 22.06 lakhs.

The financial results were reviewed by the Audit Committee and approved by the Board of Directors, with statutory auditors Kanu Doshi Associates LLP providing an unqualified review conclusion on the statements.

Historical Stock Returns for Triochem Products

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

Multiple Indian Companies Release Q3 FY26 Financial Results Under Regulation 33

1 min read     Updated on 14 Feb 2026, 11:40 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Multiple Indian companies including Tivoli Construction, Triochem Products, Arya Capital Management, Twenty Five South Realty, and Hindalco have released their Q3 FY26 financial results under Regulation 33 compliance. The unaudited standalone and consolidated results cover the quarter and nine months ended December 31, 2025, with Board approvals obtained in February 2026.

powered bylight_fuzz_icon
32595030

*this image is generated using AI for illustrative purposes only.

Multiple Indian companies have released their quarterly financial results for Q3 FY26, demonstrating compliance with regulatory disclosure requirements under SEBI guidelines. The financial disclosures cover various business sectors and provide comprehensive performance data for the quarter and nine months ended December 31, 2025.

Companies Reporting Financial Results

Several companies have submitted their unaudited standalone and consolidated financial results under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The reporting companies span different industry sectors, reflecting diverse business operations and financial performance metrics.

Company Sector Result Type
Tivoli Construction Limited Construction Standalone/Consolidated
Triochem Products Limited Chemical Products Standalone
Arya Capital Management Private Limited Financial Services Standalone
Twenty Five South Realty Limited Real Estate Standalone
Hindalco Industries Limited Metals & Mining Standalone/Consolidated

Regulatory Compliance Framework

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013. All companies have ensured compliance with the statutory requirements for quarterly financial disclosures, maintaining transparency in their financial reporting processes.

The results encompass both quarterly performance for Q3 FY26 and cumulative nine-month performance, providing stakeholders with comprehensive insights into operational efficiency and financial health across different reporting periods.

Board Approvals and Audit Processes

The financial results have received necessary approvals from respective Boards of Directors at meetings held in February 2026. The unaudited financial statements have undergone limited review processes by statutory auditors, ensuring adherence to accounting principles and regulatory standards.

These quarterly disclosures form part of the companies' ongoing commitment to maintaining transparency and providing regular updates to investors, regulators, and other stakeholders about their financial performance and business operations.

Market Disclosure Requirements

The complete financial results are available on stock exchange websites, including BSE Limited, providing public access to detailed financial information. Companies have fulfilled their obligations under SEBI regulations by ensuring timely submission and publication of their quarterly financial performance data.

The diverse range of reporting companies reflects the broad-based nature of corporate financial disclosures across different industry segments in the Indian market, demonstrating the comprehensive regulatory framework governing listed entities.

Historical Stock Returns for Triochem Products

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

More News on Triochem Products

1 Year Returns:0.00%